| Study name |
Efficacy and safety of meantime hydrochloride, a low affinity antagonist to n‐methyl‐d‐aspartate (NMDA) type receptors, in the prevention of cognitive decline and disease progression in older people with Down's syndrome, with and without dementia. |
| Methods |
Comparing memantine to placebo. |
| Participants |
Older people with Down's syndrome, with and without dementia. |
| Interventions |
Memantine and placebo. |
| Outcomes |
Details not known |
| Starting date |
Jan 7 2005 |
| Contact information |
Margallo‐Lana, Dr Maria Luisa (Northgate and Prudhoe NHS Trust and King's College London, Northgate Hospital, Morpeth, Northumberland, NE61 3BP, United Kingdom) and Wolverhampton City Primary Care Trust |
| Notes |
ISSN: N0281175554 |
